GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,000 | +111.1% | 278 | 0.0% | 0.00% | +200.0% |
| Q2 2022 | $9,000 | +28.6% | 278 | +36.3% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | +133.3% | 204 | +70.0% | 0.00% | – |
| Q3 2021 | $3,000 | -50.0% | 120 | +20.0% | 0.00% | -100.0% |
| Q3 2020 | $6,000 | 0.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $6,000 | +20.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $5,000 | -37.5% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |